NRXP

NRX Pharmaceuticals (NRXP)

About NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high

$5.40

Daily low

$4.34

Price at open

$4.83

52 Week High

$7.33

52 Week Low

$1.10

Market cap

61.7M

Dividend yield

0.00%

Volume

1.3M

Avg. volume

3.2M

P/E ratio

-2.37

NRX Pharmaceuticals News